Memorial Sloan Kettering doctors and researchers are looking for ways to better understand and treat tobacco-related addictions and behaviors.
We are experienced in selecting people who are most likely to benefit from a particular therapy, and we can help guide you through the process of enrolling in the most appropriate clinical trial.
Here you can find a continually updated listing of our current clinical trials for tobacco cessation. To learn more about a study, choose from the list below.
Research Studies
Ongoing Trials
The Freedom to Breathe Study
The purpose of this study is to evaluate how using an indoor air quality monitor can promote a smoke-free home for cancer patients who are enrolled in MSK’s Tobacco Treatment Program.
ClinicalTrials.gov ID: NCT06693700
Past Studies
Cessation & Screening to Save Lives (CASTL)
This study is to help determine the most effective type or combination of treatments to offer patients seeking lung cancer screening who are smokers to help them reduce the number of cigarettes they smoke or quit smoking. The investigators long term goal is to increase the benefits of lung cancer screening by providing a blueprint of best practices for screening sites to deliver tobacco treatment to their patients who are smokers, in a way that does not add burden to screening site staff and increases the chances of patients quitting smoking.
ClinicalTrials.gov ID NCT03315910
Quit2Heal Smartphone App in Helping Cancer Patients Quit Smoking
This phase III trial compares the Quit2Heal smoking cessation smartphone application (app) to the QuitGuide app in helping cancer patients quit smoking. Both apps provide tools to cope with urges to smoke, step-by-step guides for quitting smoking, help in planning for quitting and staying tobacco-free, and scientifically-based recommendations for how to select medications that aid in smoking cessation.
ClinicalTrials.gov ID: NCT04409236
Carbon Monoxide Monitor as a Peri-Operative Smoking Cessation Intervention Treatment (COMPOSIT)
This quality improvement project sought to improve the quality of tobacco treatment at MSK by optimizing patient engagement with our existing tobacco treatment program (TTP). COMPOSIT provided personal Carbon Monoxide (CO) monitors to patients in scheduled for surgery to be used during the peri-operative period to monitor their tobacco treatment efforts.